EyePoint Pharmaceuticals

Overview

Discover the Excitement of EyePoint Pharmaceuticals: Revolutionizing Eye Care

EyePoint Pharmaceuticals, a specialty biopharmaceutical company, is at the forefront of developing and commercializing innovative ophthalmic products to address the unmet medical needs of patients with serious eye disorders. With a commitment to improving lives through groundbreaking treatments, EyePoint Pharmaceuticals has become a leading player in the field.

EyePoint Pharmaceuticals has already achieved significant milestones, having developed three FDA-approved sustained-release treatments in ophthalmology. One of their most notable achievements is the approval of DEXYCU (dexamethasone intraocular suspension) 9% by the U.S. Food and Drug Administration (FDA) on February 9, 2018. This breakthrough treatment offers hope to patients suffering from eye disorders, providing them with a much-needed solution.

Another remarkable product in their portfolio is ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg, a micro-insert licensed to Alimera Sciences. Currently sold directly in the U.S. and several EU countries, ILUVIEN® has proven to be a game-changer in the treatment of eye disorders. Additionally, EyePoint Pharmaceuticals has licensed Retisert® (fluocinolone acetonide intravitreal implant) 0.59 mg, an implant, to Bausch & Lomb, further expanding their reach and impact in the industry.

EyePoint Pharmaceuticals is not resting on its laurels. The company's lead product candidate, DurasertTM (fluocinolone acetonide intravitreal implant) 0.18 mg micro-insert, has had its New Drug Application (NDA) accepted for filing by the U.S. Food and Drug Administration (FDA). Currently under standard review, with a Prescription Drug User Fee Act (PDUFA) date set for November 5, 2018, this potential breakthrough treatment holds great promise for patients suffering from eye disorders.

What sets EyePoint Pharmaceuticals apart is its unwavering dedication to research and development. The company's pre-clinical development program focuses on utilizing its core Durasert Technology platform to deliver drugs for the treatment of wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. By pushing the boundaries of innovation, EyePoint Pharmaceuticals is continuously striving to improve the lives of patients worldwide.

Working at EyePoint Pharmaceuticals offers employees an exciting and fulfilling experience. The company's commitment to developing innovative ophthalmic products means that employees are at the forefront of cutting-edge research and development. They have the opportunity to contribute to groundbreaking treatments that have the potential to transform the lives of patients with serious eye disorders.

EyePoint Pharmaceuticals fosters a collaborative and dynamic work environment, where employees are encouraged to think outside the box and push the boundaries of innovation. The company values the unique perspectives and expertise of its employees, recognizing that it is through their collective efforts that they can achieve their ambitious goals.

In addition to the intrinsic rewards of working on life-changing treatments, EyePoint Pharmaceuticals offers its employees a range of benefits. The company provides a comprehensive compensation package, including competitive salaries and performance-based bonuses. Employees also have access to a variety of healthcare benefits, ensuring their well-being and peace of mind.

Furthermore, EyePoint Pharmaceuticals believes in investing in the growth and development of its employees. The company offers opportunities for professional development and career advancement, providing employees with the tools and resources they need to excel in their roles. With a focus on fostering a culture of learning and innovation, EyePoint Pharmaceuticals empowers its employees to reach their full potential.

Joining EyePoint Pharmaceuticals means becoming part of a team that is revolutionizing eye care. With a track record of success and a commitment to improving the lives of patients with serious eye disorders, EyePoint Pharmaceuticals offers employees an exciting and rewarding career. By pushing the boundaries of innovation and working towards breakthrough treatments, employees have the opportunity to make a meaningful impact in the field of ophthalmology.